Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)

HeartSciences (HSCS) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $32103.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $32103.0, compared with a TTM value of $32103.0 through Oct 2024, changed N/A, and an annual FY2023 reading of $187450.0, down 19.5% over the prior year.
  • Other Non-Current Liabilities was $32103.0 for Q4 2024 at HeartSciences, down from $207592.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $232868.0 in Q2 2022 and bottomed at $32103.0 in Q4 2024.
  • Average Other Non-Current Liabilities over 3 years is $166926.3, with a median of $195514.0 recorded in 2023.
  • Peak annual rise in Other Non-Current Liabilities hit 50.46% in 2023, while the deepest fall reached 19.5% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $137967.0 in 2022, then surged by 50.46% to $207592.0 in 2023, then tumbled by 84.54% to $32103.0 in 2024.
  • Business Quant data shows Other Non-Current Liabilities for HSCS at $32103.0 in Q4 2024, $207592.0 in Q3 2023, and $187450.0 in Q2 2023.